EQT Acquires Majority Stake in CluePoints

June 12, 2024

EQT (via its Healthcare Growth strategy and the EQT Growth Fund) has agreed to acquire a majority stake in CluePoints, a Belgium-headquartered provider of AI-powered RBQM and clinical trial data analytics software. Existing investors Summit Partners and Clinimetrics SA (and management) will reinvest; the deal is intended to support CluePoints' continued product development, global expansion and entry into adjacent markets and is expected to close in Q3 2024.

Buyers
EQT (EQT Healthcare Growth and EQT Growth Fund)
Targets
CluePoints
Sellers
Summit Partners, Clinimetrics SA
Location
Belgium
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.